Please provide your email address to receive an email when new articles are posted on . Adjuvant pembrolizumab appeared associated with a significant and clinically meaningful improvement in DFS vs.

In an earlier study on kidney donors we found that nephrectomy shifts the action of Ang II from the afferent towards the efferent arteriole, 4 increasing efferent resistance and filtration pressure.

NASHVILLE, Tenn. — A fully automated artificial intelligence approach predicted post-nephrectomy glomerular filtration rate with comparable accuracy as validated clinical prediction models, according ...

Phase II Trial of Idiotype Vaccination in Previously Treated Patients With Indolent Non-Hodgkin’s Lymphoma Resulting in Durable Clinical Responses From January 1989 to July 2005, we identified ...

Minimally invasive surgery linked to lower major complication risk, reduced length of stay, decreased transfusion rate.

Renal malignancy is treated by total nephrectomy (TN) or, if the renal mass is ≤4 cm, partial nephrectomy (PN) to preserve renal function. Population-based findings on the frequency of complications ...

Kidney removal surgery, a nephrectomy, can cause pain. While most discomfort fades in weeks, some patients experience chronic pain. Understanding different pain types like flank, back, and nerve pain ...

A patient self-administers a finger prick blood test. Patients undergoing nephrectomy for RCC have a higher risk of death if they have diabetes, a new study suggests. Patients undergoing nephrectomy ...

The presence and number of kidney cysts, particularly in the medulla, may be an additional imaging-based biomarker for progressive CKD after radical nephrectomy for kidney cancer. Among patients who ...

Prediction of response to sunitinib in patients with advanced renal cell carcinoma (RCC) using mass spectrometry-based (phospho) proteomics. This is an ASCO Meeting Abstract from the 2021 ASCO Annual ...

A study investigated the safety of nephrectomy after exposure to HIF-2α antagonists for localized VHL-deficient kidney cancer.

In 1955 we had occasion to treat a patient in whom the pathologic changes were strikingly similar to that of the patient reported by Freeman et al. 1 However, our patient was normotensive before ...